MUTYH-Associated Polyposis (MAP) is an inherited colorectal polyposis syndrome caused by pathogenic variants in both copies of the MUTYH gene. The condition can lead to multiple adenomatous polyps in the colon and rectum and substantially increases the risk of colorectal cancer. MAP may also involve polyps or cancers in other organs, including the duodenum.
Some individuals may develop colorectal cancer even when they have relatively few colorectal polyps, making appropriate genetic assessment and surveillance important.
Timely diagnosis and surveillance are important because adenomatous polyps associated with MAP can gradually progress to colorectal cancer. Without appropriate surveillance, the lifetime risk of colorectal cancer can be very high. Regular colonoscopy allows doctors to identify and remove precancerous polyps before they progress. When the number or size of polyps becomes difficult to control endoscopically, colorectal surgery may be considered to reduce cancer risk.
Causes
Risk Factors
Colonoscopic Surveillance and Polyp Removal: Regular high-quality colonoscopy allows doctors to identify and remove adenomatous polyps before they progress. Surveillance intervals are generally based on individual polyp burden and clinical findings.
Preventive Colorectal Surgery: Colectomy may be considered when the number, size, or distribution of polyps makes endoscopic management inadequate, or when colorectal cancer or significant symptoms are present.
Colectomy with Ileorectal Anastomosis: In selected patients, the colon may be removed while preserving the rectum, with the small intestine connected to the remaining rectum. Continued endoscopic surveillance of the rectum is required after surgery.
Proctocolectomy with Ileal Pouch-Anal Anastomosis: When there is extensive rectal polyposis, removal of both the colon and rectum may be considered, with creation of an ileal pouch to maintain bowel continuity.
Management of Upper Gastrointestinal and Other Manifestations: Upper GI endoscopy can identify gastric, duodenal, or periampullary adenomas. Selected lesions may be removed endoscopically, while thyroid or other abnormalities may require specialist evaluation.
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support MUTYH-Associated Polyposis patients in India. These services include:









Chennai, India
Apollo Hospital located in Chennai, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:

Kolkata, India
Apollo Multispecialty Hospitals located in Kolkata, India is accredited by JCI, NABH. Also listed below are some of the most prominent infrastructural details:

Bangalore, India
Gleneagles BGS Hospital, Kengeri, is a leading healthcare centre in Bengaluru, committed to delivering compassionate, patient-focused care locally and globally. The hospital houses 15 specialised departments with over 30 medical and surgical specialities, supported by 450 beds, advanced emergency services, imaging, laboratory, and transfusion facilities.
It is renowned for pioneering initiatives such as South India’s first 5G-enabled ambulance and Karnataka’s largest Multi-Organ Transplant Program. Recognised among India’s top paediatric cranio-maxillofacial centres, it is also the first in Karnataka to receive the AHPI Award 2024 for “Excellence in Nursing Practices” consecutively.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome